EZIO Compared to Central Venous Lines for Emergency Vascular Access

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2008-09-30

Study Completion Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter randomized study to compare powered intraosseous access to standard central line access for the administration of fluids and drugs for patients in the Emergency Dept.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intraosseous Access in the Emergency Department for Patients With Failed Attempts at Intravenous Access: A Randomized Trial Examining Resource Utilization and Patient Satisfaction

NCT01676350

Difficult Peripheral IV Access

COMPLETED NA

Continuous Intraosseous Vascular Access Over 48 Hours

NCT01866475

Intraosseous Vascular Access

COMPLETED NA

Vascular Access in Hematological Patients - PICC Versus CVC

NCT02405728

Vascular Access Complication

COMPLETED NA

A Randomized Controlled Open Label Trial to Assess the Safety and Efficacy of the OptiVein IV Catheter in an Oncologic Population

NCT02420028

Intravenous Injections

TERMINATED NA

Intravenous Vs. Intraosseous Vascular Access During Out-of-Hospital

NCT05205031

Cardiac Arrest

ACTIVE_NOT_RECRUITING PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Catheters, Indwelling Central Venous Line Intraosseous Needle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

EZIO

Group Type EXPERIMENTAL

Powered Intraosseous device (EZIO)

Intervention Type DEVICE

EZIO

2

Central line

Group Type EXPERIMENTAL

standard central line

Intervention Type DEVICE

placement of a central line

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Powered Intraosseous device (EZIO)

EZIO

Intervention Type DEVICE

standard central line

placement of a central line

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Over 18 years old Requires central access after peripheral access attempts have failed or are not otherwise feasible

Exclusion Criteria

Fracture in target bone Not able to sign informed consent Excessive tissue or absence of adequate anatomical landmarks Known or suspected coagulopathies Pregnancy Patients in custody Patients with suspected great vessel injury Not fluid in English

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No